Substance / Medication

Benzyl alcohol

Overview

Active Ingredient
benzyl alcohol
RxNorm CUI
1426

Indications

® CIPROHC OTIC is indicated for the treatment of acute otitis externa in adult and pediatric patients, one year and older, due to susceptible strains of Pseudomonas aeruginosa, Staphylococcus aureus, and Proteus mirabilis.

Labeler: Physicians Total Care, Inc.Updated: 2010-12-13T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

® CIPROHC OTIC is contraindicated in persons with a history of hypersensitivity to hydrocortisone, ciprofloxacin or any member of the quinolone class of antimicrobial agents. This nonsterile product should not be used if the tympanic membrane is perforated. Use of this product is contraindicated in

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

3 trials linked to this intervention

3
Total Trials
1
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Pharmacokinetics and pharmacodynamics of propofol with or without 2% benzyl alcohol following a single induction dose administered intravenously in cats.
Griffenhagen Gregg M, Rezende Marlis L, Gustafson Daniel L et al. · Vet Anaesth Analg · 2015
PMID: 25327817RCT
Evaluation of propofol containing 2% benzyl alcohol preservative in cats.
Taylor Polly M, Chengelis Christopher P, Miller Walter R et al. · J Feline Med Surg · 2012
PMID: 22366290RCTFull text (PMC)
Photopolymerization of N,N-dimethylaminobenzyl alcohol as amine co-initiator for light-cured dental resins.
Schroeder Walter F, Cook Wayne D, Vallo Claudia I · Dent Mater · 2008
PMID: 17804051Observational
Retinal toxicity of triamcinolone's vehicle (benzyl alcohol): an electrophysiologic and electron microscopic study.
Macky Tamer A, Helmy Dina, El Shazly Nihal · Graefes Arch Clin Exp Ophthalmol · 2007
PMID: 17111149Observational
Vanillin, 4-hydroxybenzyl aldehyde and 4-hydroxybenzyl alcohol prevent hippocampal CA1 cell death following global ischemia.
Kim Hyeon Ju, Hwang In Koo, Won Moo Ho · Brain Res · 2007
PMID: 17945203Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Benzyl alcohol (substance)
SNOMED CT
55902002
UMLS CUI
C0005100
RxNorm CUI
1426
Labeler
Physicians Total Care, Inc.

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.